Related Experiment Videos
Alternatives for myocardial protection: adenosine-enhanced ischemic preconditioning
1Division of Cardiothoracic Surgery, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Annals of the New York Academy of Sciences
|July 23, 1999
Summary
Adenosine-enhanced ischemic preconditioning offers cardioprotection comparable to cold blood cardioplegia. This novel protocol significantly reduces myocardial infarct size and improves functional recovery after cardiac surgery.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Pharmacology
Background:
- Developing effective myoprotective protocols is crucial for cardiac surgery.
- New protocols must match or exceed conventional cardioplegia for functional recovery and infarct size reduction.
Purpose of the Study:
- To evaluate adenosine-enhanced ischemic preconditioning as a novel cardioprotective strategy.
- To compare its efficacy against cold blood cardioplegia in reducing myocardial damage and improving recovery.
Main Methods:
- Adenosine was administered as a bolus to the myocardium during ischemic preconditioning.
- Efficacy was assessed in isolated perfused rabbit hearts and in situ blood-perfused sheep hearts.
- Key outcomes measured included myocardial infarct size and post-ischemic functional recovery.
Main Results:
- Adenosine-enhanced ischemic preconditioning provided cardioprotection equivalent to cold blood cardioplegia.
- This method significantly decreased myocardial infarct size.
- It also significantly enhanced post-ischemic myocardial functional recovery in both experimental models.
Conclusions:
- Adenosine-enhanced ischemic preconditioning demonstrates significant cardioprotective benefits.
- It offers a promising alternative to conventional cardioplegia for reducing cardiac surgery morbidity and mortality.